Related Articles
Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: Comparison to antigen quantification by ELISA
Tissue urokinase-type plasminogen activator receptor levels in breast cancer.
BIOCHEMICAL MARKERS AS A PREDICTOR FOR LYMPH-NODE INVOLVEMENT IN PATIENTS WITH CERVICAL-CANCER OF THE UTERUS
Urokinase-type plasminogen activator induces proliferation in breast cancer cells
Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance